Ambit Drugs Limited
About Ambit Drugs Limited
Data last updated:
Ambit Drugs Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 September 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PLC044152. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Chittireddy Ravinder Reddy (Managing Director) and Regulapati Srinivas Rao.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 2 – 3 – 97/3 Road No.3 Sai Nagar Colony Nagole, Hyderabad, Telangana, India – 500068.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address2 – 3 – 97/3 Road No.3 Sai Nagar Colony Nagole, Hyderabad, Telangana, India – 500068
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Ambit Drugs Limited FY 2023 filings available
Financial Statement Summary of Ambit Drugs Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ambit Drugs Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ambit Drugs are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ambit Drugs Limited
Ambit Drugs has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Regulapati Srinivas Rao | Director | 13 Sep 2004 | 22 Years 0 Months | Current |
| Chittireddy Ravinder Reddy | Managing Director | 13 Sep 2004 | 22 Years 0 Months | Current |
| Vidya Sagar Reddy Donthri Also directs: Pratihita Foods Private Limited, Sumeda Foods Private Limited | Director | 13 Sep 2004 | 22 Years 0 Months | Current |
| Datla Venkatrama Raju | Director | 13 Sep 2004 | 22 Years 0 Months | Current |
Charges & Borrowings of Ambit Drugs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2013 | Syndicate Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ambit Drugs Limited
Employment history and EPFO contributions of people linked to Ambit Drugs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Ambit Drugs Limited
Ambit Drugs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG2004PLC044152, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PLC044152 | Current |
| U24239AP2004PLC044152 | Previous |
| U24239AP2004PTC044152 | Previous |
Recent Activity on Ambit Drugs Limited
Ambit Drugs Limited has 4 board changes on record since 2004: 4 appointments. The latest: Chittireddy Ravinder Reddy was appointed as Managing Director on 13 Sep 2004.
Credit Ratings, Litigation & Regulatory Alerts for Ambit Drugs Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ambit Drugs Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ambit Drugs Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ambit Drugs Limited
Ambit Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ambit Drugs Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ambit Drugs Limited
Ambit Drugs is an active public limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 September 2004 (22+ years old) and is registered under CIN U24239TG2004PLC044152.
Ambit Drugs has 4 current directors:
- Chittireddy Ravinder Reddy - Managing Director
- Regulapati Srinivas Rao - Director
- Vidya Sagar Reddy Donthri - Director
- Datla Venkatrama Raju - Director
No. Ambit Drugs has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ambit Drugs is U24239TG2004PLC044152. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambit Drugs was incorporated on 13 September 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chittireddy Ravinder Reddy was appointed as Managing Director on 13 Sep 2004. Datla Venkatrama Raju was appointed as Director on 13 Sep 2004. Regulapati Srinivas Rao was appointed as Director on 13 Sep 2004. Ambit Drugs has 4 board changes on record in total.
The registered office of Ambit Drugs is at 2 – 3 – 973 Road No.3 Sai Nagar Colony Nagole, Hyderabad, Telangana, India – 500068.
Ambit Drugs has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh.
Ambit Drugs operates in the chemicals industry, in the manufacturing segment.
No. Ambit Drugs is not listed on any stock exchange. It is an unlisted company.